-
EP0808905
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0808905
| EP0808905 - Adenoviral vector for the transfer of human genes in vivo [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.08.2004 Database last updated on 16.11.2024 | Most recent event Tooltip | 20.08.2004 | Application deemed to be withdrawn | published on 06.10.2004 [2004/41] | Applicant(s) | For all designated states Aventis Behring Gesellschaft mit beschränkter Haftung Postfach 1230 35002 Marburg / DE | [N/P] |
| Former [2000/20] | For all designated states Aventis Behring Gesellschaft mit beschränkter Haftung Postfach 1230 35002 Marburg / DE | ||
| Former [1997/48] | For all designated states Centeon Pharma GmbH Postfach 1230 35002 Marburg / DE | Inventor(s) | 01 /
Poller, Wolfgang Christian, Dr. Versbacher Röthe 60 97078 Würzburg / DE | [1997/48] | Application number, filing date | 97107146.9 | 30.04.1997 | [1997/48] | Priority number, date | DE1996120687 | 22.05.1996 Original published format: DE 19620687 | [1997/48] | Filing language | DE | Procedural language | DE | Publication | Type: | A2 Application without search report | No.: | EP0808905 | Date: | 26.11.1997 | Language: | DE | [1997/48] | Type: | A3 Search report | No.: | EP0808905 | Date: | 13.05.1998 | [1998/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.03.1998 | Classification | IPC: | C12N15/86, A61K48/00 | [1997/48] | CPC: |
C12N15/86 (EP,US);
C12N15/861 (KR);
A61P7/04 (EP);
C12N9/644 (EP,US);
C12Y304/21022 (EP,US);
A61K38/162 (KR);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/48] | Title | German: | Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo | [1997/48] | English: | Adenoviral vector for the transfer of human genes in vivo | [1997/48] | French: | Vecteur adénoviral pour le transfer des gènes humaines in vivo | [1997/48] | Examination procedure | 13.11.1998 | Examination requested [1999/02] | 16.04.2002 | Despatch of a communication from the examining division (Time limit: M06) | 29.01.2003 | Reply to a communication from the examining division | 18.11.2003 | Despatch of a communication from the examining division (Time limit: M04) | 30.03.2004 | Application deemed to be withdrawn, date of legal effect [2004/41] | 03.05.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/41] | Request for further processing for: | 29.01.2003 | Request for further processing filed | 29.01.2003 | Full payment received (date of receipt of payment) Request granted | 12.02.2003 | Decision despatched | Fees paid | Renewal fee | 03.05.1999 | Renewal fee patent year 03 | 02.05.2000 | Renewal fee patent year 04 | 02.05.2001 | Renewal fee patent year 05 | 02.05.2002 | Renewal fee patent year 06 | 02.05.2003 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.04.2004 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP0707071 (INTROGENE BV [NL]) [X] 1,2 * abstract * * page 3, lines 32-57; figure 8 * [Y] 3-8; | [X]WO9428938 (UNIV MICHIGAN [US]) [X] 1,2 * page 2, line 15 - page 3, line 14 * * page 4, lines 15-28 * * page 10, line 28 - page 11, line 6 *; | [X]WO9614061 (CELL GENESYS INC [US]) [X] 1,2 * abstract * * page 5, lines 3-15; examples 12-17 *; | [Y]EP0315118 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [Y] 4 * abstract *; | [A]WO9429471 (GENETIC THERAPY INC [US]) [A] 1-3,6 * the whole document *; | [PX]WO9625506 (RHONE POULENC RORER SA [FR], et al) [PX] 1-3 * page 6, line 15 - page 8, line 3; example 5 * | [DY] - T.A.G. SMITH ET AL.,, "Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice", NATURE GENETICS, NEW YORK, NY, US, (1993), vol. 5, no. 4, pages 397 - 402, XP002056917 [DY] 1,3,6 * the whole document * DOI: http://dx.doi.org/10.1038/ng1293-397 | [Y] - M.A. ROSENFELD, "Adenovirus-mediated transfer of a recombinant alpha1-antitrypsin gene to the lung epithelium in vivo", SCIENCE, WASHINGTON DC, US, (1991), vol. 252, pages 431 - 434, XP002056918 [Y] 5 * the whole document * DOI: http://dx.doi.org/10.1126/science.2017680 | [Y] - Y. YANG ET AL.,, "Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver", GENE THERAPY, BASINGSTOKE, GB, (19960101), vol. 3, pages 412 - 420, XP000576295 [Y] 1,7,8 * the whole document * | [X] - M. A. KAY ET AL, "Long-term hepatic adenovirus mediated gene expression in mice following CTLA4Ig administration", NATURE GENETICS, NEW YORK, NY, US, (199510), vol. 11, no. 2, pages 191 - 197, XP000676074 [X] 1,2,5,8 * the whole document * DOI: http://dx.doi.org/10.1038/ng1095-191 | [A] - H.A. JAFFE ET AL.,, "Adenovirus-mediated in vivo gene transfer and expression in normal rat liver", NATURE GENETICS, NEW YORK, NY, US, (1992), vol. 1, pages 372 - 378, XP002056919 [A] 1,2,5 * the whole document * DOI: http://dx.doi.org/10.1038/ng0892-372 |